A controversial report could disrupt trust in a common pregnancy drug

On Friday, reports were reported that U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. were preparing a report that suggests a potential link between taking acetaminophen during pregnancy and autism. Kenview's stock price fell by more than 10%. The report may also recommend the use of folic acid for treatment, but there is still a disagreement in the scientific community. Kenview has faced similar charges in the past, with many lawsuits dismissed for lack of conclusive evidence. The U.S. Food and Drug Administration (FDA) insists that there is no clear evidence that there is an adverse reaction to acetaminophen, and leading medical institutions also recognize the safety of taking acetaminophen during pregnancy.